Paul Hudson, Sanofi CEO (Cyril Marcilhacy/Bloomberg via Getty Images)
Sanofi snaps up new vaccine candidate and devises mRNA game plan around it — but not for what you think
Paul Hudson has spotlighted vaccines, immunology and dermatology as some of the top R&D focuses at Sanofi. His latest deal brings all of them together …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
